FMR LLC - 27 Feb 2026 SCHEDULE 13G Report for NEKTAR THERAPEUTICS COMMON STOCK (NKTR)

Filing Manager
FMR LLC
Reporting Manager
FMR LLC
Symbol
NKTR
Shares outstanding
27,358,204 shares
Disclosed Ownership
3,036,761 shares
Ownership
11%
Form type
SCHEDULE 13G
Filing time
06 Mar 2026, 10:05:20 UTC
Date of event
27 Feb 2026

Quoteable Key Fact

"FMR LLC disclosed 11% ownership in NEKTAR THERAPEUTICS COMMON STOCK (NKTR) on 27 Feb 2026."

Quick Takeaways

  • FMR LLC filed SCHEDULE 13G for NEKTAR THERAPEUTICS COMMON STOCK (NKTR).
  • Disclosed ownership: 11%.
  • Date of event: 27 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Mar 2026, 10:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
FMR LLC 11% 3,036,761 3,032,178 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson 11% 3,036,761 0 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**